Arfalasin

This classification denotes an angiotensin ii receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7E6SP93I57. European Medicines Agency schedules Arfalasin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05557MIG. Arfalasin generally arises in the molecular formula C48H67N13O11. The term ARFALASIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17.) ARFALASIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule arfalasin under HS 29332990 and SITC 51573. As of Q4 2014, ARFALASIN remains the US FDA Preferred Term for this commodity. Arfalasin bears US NLM identifiers UMLS ID C0624820 and NCI Concept Code C87430. SMILES: O=C(N1C(CCC1)C(=O)NC(c1ccccc1)C(=O)O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CCC(=O)N)CCC/N=C(/N)N)C(C)C)Cc1ccc(O)cc1)C(C)C)Cc1[nH]cnc1.